ATE438385T1 - Pharmazeutische zusammensetzung - Google Patents
Pharmazeutische zusammensetzungInfo
- Publication number
- ATE438385T1 ATE438385T1 AT06709975T AT06709975T ATE438385T1 AT E438385 T1 ATE438385 T1 AT E438385T1 AT 06709975 T AT06709975 T AT 06709975T AT 06709975 T AT06709975 T AT 06709975T AT E438385 T1 ATE438385 T1 AT E438385T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- microparticle
- pharmaceutical composition
- production
- ifn
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000011859 microparticle Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 102000006992 Interferon-alpha Human genes 0.000 abstract 1
- 108010047761 Interferon-alpha Proteins 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 abstract 1
- 229920002477 rna polymer Polymers 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0504276A GB0504276D0 (en) | 2005-03-02 | 2005-03-02 | Pharmaceutical composition |
| GB0511801A GB0511801D0 (en) | 2005-06-10 | 2005-06-10 | Pharmaceutical composition |
| PCT/GB2006/000751 WO2006092607A1 (en) | 2005-03-02 | 2006-03-02 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE438385T1 true ATE438385T1 (de) | 2009-08-15 |
Family
ID=36353665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06709975T ATE438385T1 (de) | 2005-03-02 | 2006-03-02 | Pharmazeutische zusammensetzung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080138431A1 (enExample) |
| EP (1) | EP1853227B1 (enExample) |
| JP (1) | JP2008531672A (enExample) |
| AT (1) | ATE438385T1 (enExample) |
| AU (1) | AU2006219717B2 (enExample) |
| CA (1) | CA2599329A1 (enExample) |
| DE (1) | DE602006008278D1 (enExample) |
| WO (1) | WO2006092607A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4846200B2 (ja) | 2002-04-04 | 2011-12-28 | コーリー ファーマシューティカル ゲーエムベーハー | 免疫賦活性ｇ、ｕ含有オリゴリボヌクレオチド |
| EP2883957A1 (en) | 2005-11-25 | 2015-06-17 | Zoetis Belgium S.A. | Immunostimmulatory oligoribonucleotides |
| AU2009241645B2 (en) * | 2008-05-02 | 2014-07-17 | Blink Therapeutics Limited | Products and methods for stimulating an immune response |
| RS63817B1 (sr) | 2010-07-06 | 2023-01-31 | Glaxosmithkline Biologicals Sa | Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk |
| PT2590626E (pt) | 2010-07-06 | 2016-01-26 | Glaxosmithkline Biolog Sa | Lipossomas com lípidos que têm um valor de pka vantajoso para administração de arn |
| EP2591114B1 (en) | 2010-07-06 | 2016-06-08 | GlaxoSmithKline Biologicals SA | Immunisation of large mammals with low doses of rna |
| US9770463B2 (en) * | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| HUE047796T2 (hu) | 2010-07-06 | 2020-05-28 | Glaxosmithkline Biologicals Sa | RNS bevitele több immunútvonal bekapcsolására |
| HUE058361T2 (hu) | 2010-08-31 | 2022-07-28 | Glaxosmithkline Biologicals Sa | Pegilált liposzómák immunogént kódoló RNA bejuttatására |
| ES2945135T3 (es) | 2010-10-11 | 2023-06-28 | Glaxosmithkline Biologicals Sa | Plataformas de suministro de antígenos |
| EP3854413A1 (en) | 2011-07-06 | 2021-07-28 | GlaxoSmithKline Biologicals SA | Immunogenic combination compositions and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY118835A (en) * | 1997-04-18 | 2005-01-31 | Ipsen Pharma Biotech | Sustained release compositions and the process for their preparation |
| BR0213119A (pt) * | 2001-10-03 | 2004-12-28 | Chiron Corp | Composição imunogênica e uso da mesma |
| WO2004062599A2 (en) * | 2003-01-06 | 2004-07-29 | Corixa Corporation | Certain aminoalkyl glucosaminide phosphate compounds and their use |
| AU2004225480A1 (en) * | 2003-03-26 | 2004-10-14 | Multicell Immunotherapeutics, Inc. | Selected RNA motifs to include cell death and/or apoptosis |
-
2006
- 2006-03-02 DE DE602006008278T patent/DE602006008278D1/de active Active
- 2006-03-02 AT AT06709975T patent/ATE438385T1/de not_active IP Right Cessation
- 2006-03-02 AU AU2006219717A patent/AU2006219717B2/en not_active Ceased
- 2006-03-02 JP JP2007557589A patent/JP2008531672A/ja active Pending
- 2006-03-02 US US11/885,538 patent/US20080138431A1/en not_active Abandoned
- 2006-03-02 WO PCT/GB2006/000751 patent/WO2006092607A1/en not_active Ceased
- 2006-03-02 EP EP06709975A patent/EP1853227B1/en not_active Not-in-force
- 2006-03-02 CA CA002599329A patent/CA2599329A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1853227A1 (en) | 2007-11-14 |
| WO2006092607A1 (en) | 2006-09-08 |
| CA2599329A1 (en) | 2006-09-08 |
| EP1853227B1 (en) | 2009-08-05 |
| US20080138431A1 (en) | 2008-06-12 |
| AU2006219717A1 (en) | 2006-09-08 |
| DE602006008278D1 (de) | 2009-09-17 |
| JP2008531672A (ja) | 2008-08-14 |
| AU2006219717B2 (en) | 2009-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ansari et al. | Poly (N-isopropylacrylamide)-based hydrogels for biomedical applications: A review of the state-of-the-art | |
| Rizwan et al. | pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications | |
| WO2007040469A3 (en) | Chloroquine coupled compositions and methods for their synthesis | |
| MXPA05003591A (es) | Materiales basados en ciclodextrina, composiciones y usos relacionados a los mismos. | |
| ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
| MX2009005727A (es) | Nanoparticulas de entidad anfifilica. | |
| WO2008013785A3 (en) | Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening | |
| MX2009011247A (es) | Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones. | |
| WO2006060723A3 (en) | Methods for producing block copolymer/amphiphilic particles | |
| DK1660037T3 (da) | Aripiprazol-injektionssuspension | |
| ATE438385T1 (de) | Pharmazeutische zusammensetzung | |
| TW200635618A (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
| EA201171279A1 (ru) | Производство инкапсулированных наночастиц с высокой объемной долей | |
| GEP20115200B (en) | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same | |
| EA201170039A1 (ru) | Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| EA200900572A1 (ru) | Мицеллярные наночастицы с химическими субстанциями | |
| WO2008085556A3 (en) | Surfactant-free nanoparticles for drug delivery | |
| WO2017141204A3 (en) | Biguanide grafted / modified biopolymers as drug delivery vehicles | |
| WO2005055980A3 (en) | Polymalic acid-based multifunctional drug delivery system | |
| WO2023129738A3 (en) | Modified polysaccharide polymers and related compositions and methods thereof | |
| ES2178961A1 (es) | Fabricacion de nanoparticulas a base del copolimero de metil vinil eter y anhidrido maleico para la administracion de farmacos de naturaleza hidrofilica, en particular de bases puricas y pirimidinicas. | |
| WO2006137856A3 (en) | Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility | |
| WO2008033058A3 (en) | Method for producing insulin in the form of an oral preparation | |
| NO20082848L (no) | Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |